Skip to content

LIXTE BIOTECHNOLOGY INC

LIXT

Latest QuantConomy context for LIXT: asset profile, market coverage, scored signals, and source-linked SEC insider filings when available.

Asset class
stock
Primary venue
NASDAQ
Recent signals
3
SEC filings
10
Asset profile

LIXTE BIOTECHNOLOGY INC

QuantConomy has a structured record for LIXT. More descriptive asset metadata will appear here when the platform record includes it.

Symbol
LIXT
Name
LIXTE BIOTECHNOLOGY INC
Coverage
3 market/data records
Sources
alpaca alphavantage fmp sec nasdaq openfigi
Latest signal rows

Recent signals for LIXT

Scored rows are pulled from the same signal API used by the digests.

Signal Direction Score Observed Reason
corporate event
material agreement
bullish
100
Jul 2, 08:32 PM LIXT filed 8-K: Material Definitive Agreement, Acquisition or Disposition, Unregistered Sales of Equity - 6 material events - [very strong bullish signal]
fundamental
operating income change
very bullish
76
May 14, 12:00 AM LIXT (Q1 2026, operating income): grew 61.1% (-$5.11M → -$1.99M). [sequential period basis, very bullish signal]
fundamental
eps change
very bullish
76
May 14, 12:00 AM LIXT (Q1 2026, diluted eps): EPS grew 85.7% ($-1.26 → $-0.18). [sequential period basis, very bullish signal]

FUNDAMENTAL signals are experimental: the generator was recently enabled and coverage is still being validated.

Market coverage

Market Exchange Source Asset record
LIXT NASDAQ alpaca Lixte Biotechnology Holdings, Inc. Common Stock
LIXT NASDAQ alphavantage Lixte Biotechnology Holdings Inc
LIXT NASDAQ fmp Lixte Biotechnology Holdings, Inc.

Recent insider transactions

Buys, last 90d
0
Sells, last 90d
0
Rows
10
Date Insider Role Type Shares Price Value Filing
Jul 1, 2026 Primus Guy Warren Insider grant 15,000 $0.00 $0 4 on EDGAR
May 29, 2026 Porter Stuart D Insider grant 25,000 $0.00 $0 4 on EDGAR
Apr 15, 2026 Stazzone Peter Chief Financial Officer grant 50,000 4 on EDGAR
Apr 15, 2026 Holloway Michael Andrew Insider grant 25,000 4 on EDGAR
Apr 15, 2026 Felix Lourdes Insider grant 25,000 4 on EDGAR
Apr 15, 2026 Pursglove Geordan Garrett CEO and Chairman of the Board grant 350,000 4 on EDGAR
Apr 15, 2026 Sawyer Jason David Insider grant 25,000 4 on EDGAR
Apr 15, 2026 Primus Guy Warren Insider grant 25,000 4 on EDGAR
Dec 24, 2025 Felix Lourdes Insider grant 25,000 4 on EDGAR
Dec 24, 2025 Primus Guy Warren Insider grant 25,000 4 on EDGAR

Source: SEC filings via QuantConomy. Not investment advice.

Get the data

Query LIXT context like a database.

These rows come from the QuantConomy signal, asset, market, and SEC filings API surfaces, also available to AI agents over MCP.

No spam, no noise. Just the launch and the occasional preview.

More: All insider trades · How to read a Form 4 · API access